Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – online resources
    • IMPACT
      • Workshops
      • IMPACT – online resources
      • IMPACT news
      • IMPACT partners and sponsors
    • SPECC
      • Workshops
      • Online resources
      • SPECC Partners and Sponsors
      • SPECC News
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • PELT
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
        • How your donations are spent
    • Events and Challenges
    • Leaving a Legacy
    • Fundraising
      • Our fundraisers
      • Fundraising pack
      • Fundraising opportunities
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Online Shop
  • Events
  • Contact us

SPECC Workshops

October 16, 2017 by pelicanadmin

Every Colorectal Cancer Multi-Disciplinary Team in England and Wales will receive an invitation to join a free one-day workshop on SPECC. Teams will be invited to join other hospitals from the same Strategic Clinical Network.

The programme for the workshop has been devised by an expert steering group and a general overview of the programme’s workshop content can be seen below. The speakers at every workshop will be a mix of national and local experts, with local clinicians joining the faculty within each network.

Forthcoming SPECC Workshops

So far there have been 9 workshops attended by 660 clinicians from 94 NHS trusts. We are running the following workshops:

Cardiff, Wales – 29th November 2017

Bristol, South West of England – 8th December 2017

If you would like to book onto any of these courses please download our booking form and return it completed to admin@pelicancancer.org.

Sample Workshop Content Overview

Workshop Aims: To advance local and regional practice in the definition, recognition, documentation, treatment and strategic planning for significant polyps and early colorectal cancer.

Background
• Strengths and local interest; who does what within the region

Case Study
• Stimulating discussion & debate on the diagnosis and management of a SPECC lesion

Definition and Anatomy | Surgeon
• A significant polyp is a large (20mm) sessile or flat colorectal lesion
• Early colorectal cancer is generally a small (3cm) malignant colorectal lesion with a low risk of nodal involvement.

Screening | Epidemiologist
• Changing incidence of SPECC with screening era

The overall pathway for SPECC patients | Gastroenterologist
• Endoscopy tips, tricks, tools, and troubleshooting

Recognition and assessment | Gastroenterologist
• Endoscopic assessment, characterization, documentation
• Strategic planning – today or another day / another place / another person?
• Endoscopic adjuncts, chromo-endoscopy, narrow band imaging

Triple assessment for rectal lesions | Surgeon
• Planning optimal management, more than staging accuracy
• Different endorectal ultrasound platforms and their use by the surgeon – when and how to use ultrasound

Significant lesions on MRI Rectum | Radiologist
• Staging with MRI for rectal SPECC to assess depth of invasion and lymph node involvement

CT colonoscopy: in detecting polyps and early cancer | Radiologist
• Outline principles of CTC – bowel preparation – full mechanical versus tagged faeces
• Methods, tips, tricks and tools

Case study for SPECC managed by endoscopic treatment | Gastroenterologist
• A case that might be commonly found but universally challenging and controversial

The pathologists view? | Pathologist
• Technical difficulties in categorizing benign or malignant polyps

The patient perspective | Colorectal Nurse Specialist
• Balancing risk and individual choice – cases to demonstrate different individual choices?

Endoscopic excision techniques – EMR/ESD | Gastroenterologist
• Advantages and challenges of EMR and ESD, tips, tricks

Transanal excision for rectal lesions | Surgeon
• Suspected early rectal cancer management – indications, evidence, technique and follow-up

Contact X-ray Brachytherapy (Papillon) | Oncologist
• What is brachytherapy, who is it suitable for and how does it work

Filed Under: Uncategorized

Pelican Cancer FoundationFollow

Pelican Cancer Foundation
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
22 Dec

We would like to wish you all a very Merry Christmas and a peaceful New Year - especially to all the wonderful key workers, who will be working throughout. 🎄🥂🎁

Reply on Twitter 1341352794255593477Retweet on Twitter 1341352794255593477Like on Twitter 13413527942555934771Twitter 1341352794255593477
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
7 Dec

👏

Reply on Twitter 1335864743752589312Retweet on Twitter 1335864743752589312Like on Twitter 13358647437525893122Twitter 1335864743752589312
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
5 Dec

Let loved ones know that you are thinking of them over the festive period and send a handwritten Christmas card. Order your Christmas cards from us at http://www.pelicancancer.org/shop. 🎄(Royal Mail’s latest recommended posting dates are 18th Dec (2nd Class) and 21st Dec (1st Class). 🎄

Reply on Twitter 1335126762079068160Retweet on Twitter 1335126762079068160Like on Twitter 1335126762079068160Twitter 1335126762079068160
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in